|Bid||7.66 x 1300|
|Ask||7.94 x 900|
|Day's range||7.63 - 8.20|
|52-week range||6.68 - 53.61|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Immunovant, Inc. ( NASDAQ:IMVT ) insiders who purchased shares in the last 12 months were richly rewarded last week...
Immunovant's (IMVT) earnings miss estimates in second-quarter fiscal 2022 (ended Sep 30, 2021). Focus remains on lead pipeline candidate IMVT-1401.
Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.